Automated description from the Alliance of Genome Resources
Exhibits oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Involved in several processes, including negative regulation of macrophage chemotaxis; reproductive structure development; and testosterone biosynthetic process. Predicted to localize to several cellular components, including the dendritic spine; neuronal cell body; and synaptic vesicle. Used to study Sjogren's syndrome and aromatase excess syndrome. Human ortholog(s) of this gene implicated in several diseases, including aromatase excess syndrome; bladder neck obstruction; endometriosis (multiple); polycystic ovary syndrome; and prostate disease (multiple). Is expressed in central nervous system; early conceptus; gonad; and retina. Orthologous to human CYP19A1 (cytochrome P450 family 19 subfamily A member 1).